Compounds > n-methylquipazine
Page last updated: 2024-08-16

n-methylquipazine and quipazine

n-methylquipazine has been researched along with quipazine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Rahman, AA; Dukat, M; Glennon, RA; Gyermek, L; Ingher, S; Ismaiel, AM; Teitler, M1
Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S1
Anzini, M; Bruni, G; Canullo, L; Cappelli, A; De Benedetti, PG; Donati, A; Doucet, E; Giorgi, G; Hamon, M; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S1
Eriksson, L; Ingvar, M; Stone-Elander, S; Thorell, JO1
Ashby, CR; Kurachi, M; Kurata, K; Oberlender, R; Rini, NJ; Strecker, RE; Tanii, Y1

Other Studies

5 other study(ies) available for n-methylquipazine and quipazine

ArticleYear
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
    Journal of medicinal chemistry, 1996, Sep-27, Volume: 39, Issue:20

    Topics: Animals; Biguanides; Heart Rate; Male; Molecular Structure; Muscle Contraction; Piperazines; Rabbits; Rats; Receptors, Serotonin; Reflex; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Urinary Bladder

1996
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5

    Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured

1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9

    Topics: Animals; Binding, Competitive; Brain; Cell Line; Granisetron; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship

1999
N-methylquipazine: carbon-11 labelling of the 5-HT3 agonist and in vivo evaluation of its biodistribution using PET.
    Nuclear medicine and biology, 1997, Volume: 24, Issue:5

    Topics: Animals; Carbon Radioisotopes; Isotope Labeling; Macaca fascicularis; Male; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Tissue Distribution; Tomography, Emission-Computed

1997
The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study.
    Synapse (New York, N.Y.), 1996, Volume: 24, Issue:4

    Topics: alpha-Methyltyrosine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dopamine; Indoles; Male; Microdialysis; Prefrontal Cortex; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

1996